
Categories
- blocking peptide
- Blog
- blood
- cDNA
- ChiP
- coli recombinant
- colorimetric
- Control
- Cultrex
- Default
- Dot
- EIA
- electrophoresis
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
- Goat
- Rabbit
- Species
- The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs.
- What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.
Recent Posts
Tags
Our first summer school on #chromatin biology kicks off today: an exciting 12-day training packed with lectures from #epigenetics leaders, practical courses, knowledge-sharing, and networking. Many thanks, @METorresPadilla, @robert_ife, Aloys Schepers for hosting and organizing!
2Congratulations to the teams at @KirOxford @InflamAge_UoB @BrighamResearch on this exciting publication. Great use of #scRNA-seq and #CellDIVE #multiplex tissue imaging to reveal two types of #fibroblasts shared across 4 chronic #inflammatory diseases. ➡️ https://www.cell.com/med/fulltext/S2666-6340(22)00184-2
⏰ Deadline approaching:
Join @laoneill111 and @evanna_mills and present at our upcoming #immunometabolism conference in #Boston, Nov 7-8. Submit your abstract for a talk before Sept 1 – here 👇
https://www.abcam.com/events/immunometabolism-fundamentals-to-prospective-new-therapies
@DanaFarber @harvardmed @tcdbi